Zobrazeno 1 - 10
of 2 517
pro vyhledávání: '"De Velasco G"'
Autor:
Powles, T., Albiges, L., Bex, A., Comperat, E., Grünwald, V., Kanesvaran, R., Kitamura, H., McKay, R., Porta, C., Procopio, G., Schmidinger, M., Suarez, C., Teoh, J., de Velasco, G., Young, M., Gillessen, S.
Publikováno v:
In Annals of Oncology August 2024 35(8):692-706
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ghanem, I., Lora, D., Herradón, N., de Velasco, G., Carretero-González, A., Jiménez-Varas, M.Á., Vázquez de Parga, P., Feliu, J.
Publikováno v:
In ESMO Open June 2022 7(3)
Autor:
Grande, E., Alonso-Gordoa, T., Reig, O., Esteban, E., Castellano, D., Garcia-del-Muro, X., Mendez, M.J., García-Donas, J., González Rodríguez, M., Arranz-Arija, J.A., Lopez-Criado, P., Molina-Cerrillo, J., Mellado, B., Alvarez-Fernandez, C., De Velasco, G., Cuéllar-Rivas, M.A., Rodríguez-Alonso, R.M., Rodríguez-Moreno, J.F., Suarez-Rodriguez, C.
Publikováno v:
In ESMO Open April 2022 7(2)
Autor:
Bamias, A., Merseburger, A.S., Loriot, Y., James, N., Choy, E., Castellano, D., Lopez-Rios, F., Calabrò, F., Kramer, M., de Velasco, G., Zakopoulou, R., Tzannis, K., Sternberg, C.N.
Publikováno v:
In ESMO Open June 2021 6(3)
Autor:
Osorio L; Servicio de Urología, Urología Hospitalaria, Hospital HM La Rosaleda, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria HM Hospitales (IISHM), Madrid, Spain., Grazioso TP; Instituto de Investigación Sanitaria HM Hospitales (IISHM), Madrid, Spain.; Laboratory of Innovation in Oncology, Gynecological, Genitourinary and Skin Cancer Unit, HM CIOCC, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain.; Institute of Applied Molecular Medicine (IMMA), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo CEU, Madrid, Spain., de Velasco G; Hospital Universitario 12 de Octubre, Madrid, Spain., Etxaniz O; Grupo de Investigación Aplicada en Oncología de Badalona (B·ARGO), Hospital Germá Trials I Pujol, Barcelona, Spain., Pérez-Gracia JL; Clínica Universidad de Navarra, Pamplona, Spain., Pinto Á; Medical Oncology Department, Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Durán I; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Grande E; Medical Oncology Department, MD Anderson Cancer Center Madrid, Madrid, Spain., Garcia PB; Hospital Universitario de Cáceres, Cáceres, Spain., Lázaro M; Hospital Álvaro Cunqueiro, Vigo, Spain., Rodriguez L; Hospital Universitario de Fuenlabrada, Madrid, Spain., Villalobos ML; Hospital Universitario Príncipe de Asturias, Madrid, Spain., García L; Hospital de Segovia, Segovia, Spain., Cuellar A; Institut Català d'Oncologia, Badalona, Spain., Solís-Hernández MP; Hospital Universitario Central de Asturias, Oviedo, Spain., Pernaut C; Hospital Universitario Severo Ochoa, Madrid, Spain., Rodríguez-Moreno JF; Instituto de Investigación Sanitaria HM Hospitales (IISHM), Madrid, Spain.; Laboratory of Innovation in Oncology, Gynecological, Genitourinary and Skin Cancer Unit, HM CIOCC, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain.; Institute of Applied Molecular Medicine (IMMA), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo CEU, Madrid, Spain., Rodriguez-Antona C; Pharmacogenomics and Tumor Biomarkers Group, Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) CSIC/UAM, Madrid, Spain. crodriguezan@iib.uam.es.; Grupo de Cáncer Endocirno Hereditario, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid, Spain. crodriguezan@iib.uam.es., García-Donas J; Instituto de Investigación Sanitaria HM Hospitales (IISHM), Madrid, Spain. jgarciadonas@hmhospitales.com.; Laboratory of Innovation in Oncology, Gynecological, Genitourinary and Skin Cancer Unit, HM CIOCC, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain. jgarciadonas@hmhospitales.com.; Institute of Applied Molecular Medicine (IMMA), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo CEU, Madrid, Spain. jgarciadonas@hmhospitales.com.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Autor:
Rioja P; Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru. Electronic address: prioja@inen.sld.pe., Rey-Cardenas M; Department of Medical Oncology, Gustave Roussy, Paris Saclay University, Villejuif, France., De Velasco G; Department of Medical Oncology, University Hospital 12 de Octubre, Instituto de investigación (imas12), Madrid, Spain.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2024 Sep; Vol. 129, pp. 102801. Date of Electronic Publication: 2024 Jul 17.
Autor:
El Zarif T; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xie W; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zarba M; Tom Baker Cancer Centre, University of Calgary, Calgary, Canada., Issa W; Department of Internal Medicine, Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA., Zhang T; Department of Internal Medicine, Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA., Nguyen CB; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Alva A; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Fahey CC; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Beckermann KE; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Karam JA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Campbell MT; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Procopio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Stellato M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Buti S; Department of Medicine and Surgery, University of Parma, Parma, Italy; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Zemankova A; Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic., Melichar B; Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna 40138, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna 40138, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Venugopal B; Beatson West of Scotland Cancer Centre, Glasgow, UK; University of Glasgow, Glasgow, UK., Ebrahimi H; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., de Velasco G; Hospital Universitario 12 de Octubre, Madrid, Spain., Gurney HP; Macquarie University, Sydney, Australia., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Parikh O; Royal Preston Hospital-Lancashire Teaching Hospitals National Health Service Foundation Trust, Preston, UK., Winquist E; The Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada., Master V; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Garcia AR; Hospital 1ro de Octubre, Mexico City, Mexico., Cutuli HJ; Hospital Sirio Libanés, Buenos Aires, Argentina., Ferguson TR; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Western Australia, Australia., Gross-Goupil M; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pal SK; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Braun DA; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., McKay RR; Department of Medical Oncology, UC San Diego, La Jolla, CA, USA., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, Canada., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: toni_choueiri@dfci.harvard.edu.
Publikováno v:
European urology [Eur Urol] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Autor:
Romero-Laorden N; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain; Cátedra UAM-Fundación Instituto Roche de Medicina Personalizada de Precisión, Madrid, Spain., Lorente D; Medical Oncology Department, Hospital Provincial de Castellón, Castellón de la Plana, Spain., de Velasco G; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Biomarkers in Genito-Urinary Cancers Group, I+12 Biomedical Research Institute, Madrid, Spain., Lozano R; Medical Oncology Department, Hospital Universitario de Salamanca, Salamanca, Spain., Herrera B; Urology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain; Genitourinary Cancers Traslational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Puente J; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain., López PP; Genomics and Therapeutics in Prostate Cancer Group, I+12 Biomedical Research Institute, Madrid, Spain., Medina A; Fundación Centro Oncológico de Galicia, A Coruña, Spain., Almagro E; Hospital Universitario Quirón, Pozuelo de Alarcón, Spain., Gonzalez-Billalabeitia E; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Biomarkers in Genito-Urinary Cancers Group, I+12 Biomedical Research Institute, Madrid, Spain., Villla-Guzman JC; Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., González-Del-Alba A; Department of Medical Oncology, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain., Borrega P; Hospital San Pedro de Alcántara, Cáceres, Spain., Laínez N; Department of Medical Oncology, Navarra University Hospital, Pamplona, Spain., Fernández-Freire A; Hospital Universitario Torrecárdenas, Almería, Spain., Hernández A; Medical Oncology Department, Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastián, Spain., Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, CIBERONC, IMIM Research Institute, Barcelona, Spain., Chirivella I; Medical Oncology Department, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain., Fernandez-Parra E; Hospital Universitario de Valme, Sevilla, Spain., López-Campos F; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Isabel Pacheco M; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Fernández O; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Villatoro R; Hospital Universitario Costa del Sol, Marbella, Spain., Luque R; Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain., Hernando S; Fundación Hospital Alcorcón, Alcorcón, Spain., Castellano DC; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Biomarkers in Genito-Urinary Cancers Group, I+12 Biomedical Research Institute, Madrid, Spain., Castro E; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Translational Cancer Genetics Group, I+12 Biomedical Research Institute, Madrid, Spain., Olmos D; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Genomics and Therapeutics in Prostate Cancer Group, I+12 Biomedical Research Institute, Madrid, Spain. Electronic address: dolmos.imas12@h12o.es.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 447-455. Date of Electronic Publication: 2023 Oct 12.
Autor:
García-Donas J; HM Hospitales-Centro Integral Oncológico Clara Campal, Madrid, Spain. jgarciadonas@hmhospitales.com., de Velasco G; Hospital Universitario 12 de Octubre, Madrid, Spain., Madurga R; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain., Chamorro J; Hospital Universitario Ramón y Cajal, Madrid, Spain., Rosero D; Hospital Universitario Ramón y Cajal, Madrid, Spain., Etxaniz O; Hospital Germá Trials I Pujol, Barcelona, Spain., Pérez-Gracia JL; Clínica Universidad de Navarra, Pamplona, Spain., Pinto Á; Hospital Universitario La Paz, Madrid, Spain., Cacho D; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Barba M; HM Hospitales-Centro Integral Oncológico Clara Campal, Madrid, Spain., Borrega P; Hospital Universitario de Cáceres, Cáceres, Spain., Lázaro M; Hospital Álvaro Cunqueiro, Vigo, Spain., Rodriguez L; Hospital Universitario de Fuenlabrada, Madrid, Spain., Villalobos L; Hospital Universitario Príncipe de Asturias, Madrid, Spain., García L; Hospital de Segovia, Segovia, Spain., Cuellar A; Institut Català d'Oncologia, Badalona, Spain., Solís-Hernández MP; Hospital Universitario Central de Asturias, Oviedo, Spain., González A; Hospital Virgen de la Salud, Toledo, Spain., Pernaut C; Hospital Severo Ochoa, Madrid, Spain., Rodríguez-Moreno JF; HM Hospitales-Centro Integral Oncológico Clara Campal, Madrid, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Mar; Vol. 26 (3), pp. 732-738. Date of Electronic Publication: 2023 Aug 09.